BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1554500)

  • 21. Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.
    Linch DC; Levinsky RJ; Rodeck CH; Maclennan KA; Simmonds HA
    Clin Exp Immunol; 1984 May; 56(2):223-32. PubMed ID: 6610509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management options: SCIDS with adenosine deaminase deficiency.
    Hilman BC; Sorensen RU
    Ann Allergy; 1994 May; 72(5):395-403; quiz 403-4, 407. PubMed ID: 8179225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
    Rogers MH; Lwin R; Fairbanks L; Gerritsen B; Gaspar HB
    J Pediatr; 2001 Jul; 139(1):44-50. PubMed ID: 11445793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
    Nespoli L; Porta F; Locatelli F; Aversa F; Carotti A; Lanfranchi A; Gibardi A; Marchesi ME; Abate L; Martelli MF
    Haematologica; 1990; 75(6):546-50. PubMed ID: 2098297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
    Liston A; Enders A; Siggs OM
    Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
    Apasov SG; Blackburn MR; Kellems RE; Smith PT; Sitkovsky MV
    J Clin Invest; 2001 Jul; 108(1):131-41. PubMed ID: 11435465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses.
    Felsburg PJ; Somberg RL; Perryman LE
    Immunodefic Rev; 1992; 3(4):277-303. PubMed ID: 1449787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary immunodeficiencies: molecular aspects and treatment.
    Fischer A
    Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe combined immunodeficiencies (SCID).
    Fischer A
    Clin Exp Immunol; 2000 Nov; 122(2):143-9. PubMed ID: 11091267
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adenosine deaminase 1 deficiency, an inborn error of metabolism underlying a severe form of combined immunodeficiency].
    Giraud A; Lavocat MP; Cremillieux C; Patural H; Thouvenin S; David A; Perignon JL; Stephan JL
    Arch Pediatr; 2015 Jun; 22(6):630-5. PubMed ID: 25842197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
    Sponzilli I; Notarangelo LD
    Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients.
    Malacarne F; Benicchi T; Notarangelo LD; Mori L; Parolini S; Caimi L; Hershfield M; Notarangelo LD; Imberti L
    Eur J Immunol; 2005 Nov; 35(11):3376-86. PubMed ID: 16276484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern management of primary T-cell immunodeficiencies.
    Pachlopnik Schmid J; Güngör T; Seger R
    Pediatr Allergy Immunol; 2014 Jun; 25(4):300-13. PubMed ID: 24383740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
    Borte S; Wang N; Oskarsdóttir S; von Döbeln U; Hammarström L
    Ann N Y Acad Sci; 2011 Dec; 1246():118-30. PubMed ID: 22236436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
    Ozdemir O
    Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).
    Hershfield MS
    Immunodeficiency; 1993; 4(1-4):93-7. PubMed ID: 8167743
    [No Abstract]   [Full Text] [Related]  

  • 39. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry.
    Azzari C; la Marca G; Resti M
    J Allergy Clin Immunol; 2011 Jun; 127(6):1394-9. PubMed ID: 21624616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.
    Lanfranchi A; Lougaris V; Notarangelo LD; Soncini E; Comini M; Beghin A; Bolda F; Montanelli A; Imberti L; Porta F
    Clin Immunol; 2018 Aug; 193():118-120. PubMed ID: 29355610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.